Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study

Blood ◽  
2001 ◽  
Vol 98 (10) ◽  
pp. 3174-3174 ◽  
Author(s):  
Andrea Bacigalupo ◽  
Teresa Lamparelli ◽  
Francesca Gualandi ◽  
Stefania Bregante ◽  
AnnaMaria Raiola ◽  
...  
Keyword(s):  
Acute Leukemia ◽  
Marrow Transplantation ◽  
Randomized Study ◽  
High Dose ◽  
Increased Risk ◽  
Leukemia Relapse ◽  
Allogeneic Marrow Transplantation ◽  
Allogeneic Marrow

scholarly journals High versus low dose cyclosporine-A, after allogeneic marrow transplantation in leukemia: Long-term follow-up of a randomized study

2018 ◽  
Vol 93 (8) ◽  
pp. E185-E186
Author(s):  
Andrea Bacigalupo ◽  
Maria Teresa Van Lint ◽  
Simona Sica ◽  
Luca Laurenti ◽  
Maria Belen Rosales ◽  
...  
Keyword(s):  
Cyclosporine A ◽  
Marrow Transplantation ◽  
Low Dose ◽  
Randomized Study ◽  
Long Term Follow Up ◽  
Allogeneic Marrow Transplantation ◽  
Allogeneic Marrow

Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.

1985 ◽  
Vol 3 (11) ◽  
pp. 1490-1494 ◽  
Author(s):  
F R Appelbaum ◽  
K M Sullivan ◽  
E D Thomas ◽  
C D Buckner ◽  
R A Clift ◽  
...  
Keyword(s):  
Complete Remission ◽  
Hodgkin's Disease ◽  
Marrow Transplantation ◽  
Hodgkin’S Disease ◽  
The Other ◽  
High Dose ◽  
Allogeneic Marrow Transplantation ◽  
Allogeneic Marrow ◽  
Transplant Procedure ◽  
Severe Mucositis

Eight patients with disseminated Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) chemotherapy were treated with high-dose chemoradiotherapy and marrow transplantation from an HLA-identical sibling. Two patients remain alive in unmaintained complete remission (CR) at 38 and 39 months after transplant. In the other six patients, reasons for failure included relapse of lymphoma (two patients), or death due to complications of the transplant procedure, including Legionnaire's disease, disseminated zoster, graft-v-host disease, and aspiration pneumonia secondary to severe mucositis. These results demonstrate that some patients with MOPP-resistant Hodgkin's disease can obtain prolonged CR following intensive chemoradiotherapy and allogeneic marrow transplantation.

Bone-Marrow Ablation and Allogeneic Marrow Transplantation in Acute Leukemia

1980 ◽  
Vol 302 (19) ◽  
pp. 1041-1046 ◽  
Author(s):  
Karl G. Blume ◽  
Ernest Beutler ◽  
Klaus J. Bross ◽  
Ram K. Chillar ◽  
Owen B. Ellington ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Acute Leukemia ◽  
Marrow Transplantation ◽  
Allogeneic Marrow Transplantation ◽  
Bone Marrow Ablation ◽  
Marrow Ablation ◽  
Allogeneic Marrow

Allogeneic marrow transplantation for acute leukemia in relapse

1982 ◽  
Vol 6 (3) ◽  
pp. 383-387 ◽  
Author(s):  
Christopher Badger ◽  
C. Dean Buckner ◽  
E. Donnall Thomas ◽  
Reginald A. Clift ◽  
Jean E. Sanders ◽  
...  
Keyword(s):  
Acute Leukemia ◽  
Marrow Transplantation ◽  
Allogeneic Marrow Transplantation ◽  
Allogeneic Marrow
Sign in / Sign up

Export Citation Format

Share Document